Drug Delivery Technology

Cell Therapy Production/

Biopharmaceutical Production

Immunology/Microbiology

Business
Development

Product
Launch

Technology
Assessment

Randall Engler

CEO, Sea.Bio

Randy focuses the efforts of Sea.Bio on global business development of B2B technologies in therapeutic, diagnostic and device markets. With a significant technical background and years of business development, sales and marketing experience, Randy can help you make better decisions by defining, targeting and implementing your business plans for successful commercialization of your technology.